BAKER BROS. ADVISORS LP
Director; Director, 10% Owner · 9 filings · Latest: Jun 3, 2026
ACADIA PHARMACEUTICALS INC
BeOne Medicines Ltd.
Denali Therapeutics Inc.
INCYTE CORP
Kiniksa Pharmaceuticals International, plc
Prelude Therapeutics Inc
Replimune Group, Inc.
TScan Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
DNLI | BAKER BROS. ADVISORS LP | Director | Jun 3, 2026 | Grant/Award | $0.00 | 12,816 | — | 3,422,366 | |
ACAD | BAKER BROS. ADVISORS LP | Director, 10% Owner | May 29, 2026 | Grant/Award | $0.00 | 37,244 | — | 39,384,587 | |
KNSA | BAKER BROS. ADVISORS LP | Director | May 29, 2026 | Grant/Award | $0.00 | 12,156 | — | 2,744,894 | |
ONC | BAKER BROS. ADVISORS LP | Director | May 22, 2026 | Sale | $23.82 | 10,998 | $262.0K | 142,570 | |
INCY | BAKER BROS. ADVISORS LP | Director, 10% Owner | May 8, 2026 | Option Exercise | $84.53 | 30,000 | $2.5M | 28,203,718 | |
INCY | BAKER BROS. ADVISORS LP | Director, 10% Owner | Mar 31, 2026 | Grant/Award | $0.00 | 842 | — | 28,188,718 |